News
Leniolisib for treating activated phosphoinositide 3-kinase delta syndrome in people 12 years and over HST33 23 April 2025 23 April 2025 ...
Automated templates on the Halo Intelligence platform will allow clinicians to rapidly identify the most effective treatment plan for each patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback